Utilising the extensive range of data assets exclusively available to IQVIA, combined with our market leading expertise, we are able to support the NHS meet the challenge of delivering high quality, efficient and cost effective healthcare by identifying actionable insight and realising the value in data.
Learn MoreWe believe in the UK’s potential to become a global leader in the life sciences sector, and our investments announced in the 2018 Second Life Sciences Sector Deal further support the UK Government and the industry’s aim to make that potential a reality.
Learn MoreWe are committed to providing solutions that inform and enable all stakeholders across UK healthcare, to innovate with confidence, maximise opportunities, and, ultimately, drive human health outcomes forward.
Learn More
IQVIA’s Pharmacy Communications offers pharma companies a simple and cost-effective channel to communicate product changes, updates and patient advice directly to patients via pharmacists.
Learn MoreExplore our library of resources spanning the healthcare & life science ecosystem on the latest topics, trends, and market developments that matter to you.
Learn More
These studies aim to explore various pathologies and their treatments, as well as the use, perception and possible future applications of specific treatments, services and health products.
They will be offered to you based on your primary medical speciality.
The pathologies studied include, among others: different types of cancer (solid and liquid tumours), autoimmune diseases, depression, respiratory, rheumatological, dermatological, cardiological, neurological, endocrinological conditions.
Most medical specialities are involved.
The duration of each study typically ranges from 10 to 60 minutes.
The questionnaires remain consistent over time, with intervals typically being monthly, quarterly, or annually.
Examples: Autoimmune diseases treated with biotherapies, multiple myeloma, non-small cell lung cancer, prostate cancer.
These studies are generally conducted online, by telephone, or via videoconference.
These studies aim to identify, characterise or quantify a safety risk for patients, confirm the safety profile of an authorised drug, or assess the effectiveness of risk management measures.
They provide a comprehensive overview of a drug's safety once it has been placed on the market.
These studies aim to identify influential experts in specific medical or scientific fields in order to understand their impact and reach within the medical community.
At IQVIA, research studies are strictly governed by multiple regulations to protect participants and ensure the integrity of the data collected.
This framework is essential to guarantee transparency, legal compliance, and ethical standards, while also supporting innovation and the development of new therapies.
Your data is anonymised and processed in compliance with the GDPR. No identifiable patient information is collected.
Your contribution is essential to improving healthcare practices. Take the opportunity to participate in innovative studies that can lead to more effective treatments for patients.
